Breast Density Legislation and Clinical Evidence
| Autor: | Regina J. Hooley |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Oncology
medicine.medical_specialty Health Information Exchange Breast Neoplasms Legislation 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Breast cancer Internal medicine medicine Humans Mammography Radiology Nuclear Medicine and imaging Clinical significance Breast skin and connective tissue diseases Breast Density Modalities medicine.diagnostic_test business.industry Cancer General Medicine medicine.disease Magnetic Resonance Imaging United States Tomosynthesis 030220 oncology & carcinogenesis Relative risk Female Ultrasonography Mammary business |
| Zdroj: | Radiologic Clinics of North America. 55:513-526 |
| ISSN: | 0033-8389 |
| DOI: | 10.1016/j.rcl.2016.12.006 |
| Popis: | Breast density inform legislation is widely accepted in the United States and has fueled research regarding the clinical significance of dense breast tissue present on mammography and the value of supplemental screening. This article reviews the origins and current status of breast density inform laws and strategies for optimal breast density determination. Clinical evidence that dense breast tissue is associated with increased breast cancer risk is presented, together with a review of relative risk compared with other risk factors. Finally, there is in-depth analysis regarding the rationale, benefits, and risks of supplemental screening modalities, including ultrasound, tomosynthesis, and MRI. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|